Yinjun Lou

7PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
Efficacy and safety of short-course blinatumomab in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia.

Ge Liu, Yile Zhou, Yinjun Lou

|Jul 22, 2025
Venetoclax plus arsenic and all-trans retinoic acid in patients with relapsed/refractory acute promyelocytic leukemia.

Bingqian Jiang, Hongyan Tong, Min Yang

|Mar 16, 2025
Characteristics and predictors of central nervous system relapse in newly diagnosed acute promyelocytic leukemia in the era of arsenic: a 13-year monocenter cohort study.

Bingqian Jiang, Hongyan Tong, Haitao Meng

|Apr 06, 2022
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Yu-Ting Dai, Fan Zhang, Hai Fang

|Jan 26, 2021
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Li Chen, Hong-Ming Zhu, Yan Li

|Jul 01, 2020
PML-RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy-free postremission approach: A multiple institution experience.

Yinjun Lou, Ying Lu, Xingnong Ye

Pageof 2

Frequent Collaborators

3 joint publications

Huafeng Wang

2 joint publications

De-Pei Wu

2 joint publications

Sai-Juan Chen

2 joint publications

Jie Jin